VIJAY KUMAR: Open Payments
NPI 1477747145 · NORTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 36 payments from 10 companies in 2025. Trend: 2023 $469 · 2024 $587 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $196 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, FARXIGA, Auvelity, TRINTELLIX, ZORYVE, XHANCE, CAPLYTA, NUZYRA.
Industry payments across VA — which companies pay providers there.
